Skip to main content
. 2021 Apr 19;2021(4):CD012654. doi: 10.1002/14651858.CD012654.pub2

NCT01479426.

Methods Parallel randomized double‐blinded trial
Participants Men aged 35 to 65 years with International Index of Erectile Function ‐ 5 score between 13 and 21
Interventions
  • EFLA400 Korean red ginseng

  • Placebo

Outcomes Primary Outcome: International Index of Erectile Function ‐ 5 score
Secondary Outcomes
  • Male Sexual Health Questionnaire

  • Global Efficacy Assessment Question

  • Uroflowmetry (max flow rate)

  • International Index of Erectile Function ‐ total domain

Notes Available from: clinicaltrials.gov/ct2/show/NCT01479426